1. "Breast Medicine Service"
Formats
  1. Journal Article (2170)
  2. Meeting Abstract (1650)
  3. Review (78)
  4. Book Section (67)
  5. Editorial (42)
  6. Conference Paper (28)
  7. Guidelines (26)
  8. Correspondence (16)
  9. Miscellaneous (11)
  10. Research Letter (10)
  11. Book Whole (5)
Groups
  1. Breast Medicine Service (4103)
  2. Department of Medicine (4103)
  3. Solid Tumor Oncology Division (4103)
  4. Survivorship Research (2337)
  5. GSK Faculty (1492)
  6. Population Sciences Research Program (1339)

More Groups

People
  1. Clifford Hudis (905)
  2. Larry Norton (758)
  3. Mark Robson (676)
  4. Neal Rosen (425)
  5. Andrew Seidman (318)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (57)
  2. 2024 (192)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (802)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (169)
  4. Annals of Oncology (158)
  5. Clinical Cancer Research (128)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (853)
  2. American Association for Cancer Research (749)
  3. Springer (329)
  4. Elsevier Inc. (322)
  5. Oxford University Press (278)
  6. Nature Publishing Group (273)

More Publishers

Results (4103)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identification of biomarkers of response and the mechanism of action of a selective androgen receptor modulator in estrogen receptorpositive breast cancer patient-derived xenografts
    Meeting Abstract

    Monserrat, L.; García García, J.; Gutiérrez, C. M.; Viaplana, C.; Brasó-Maristany, F.; Bellet, M.; Chandarlapaty, S.; Nonell, L.; Ponomarenko, J.; Canals, F.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Final OS analysis from the phase 3 TROPiCS-02 study: sacituzumab govitecan in HR+/HER2 - metastatic breast cancer
    Meeting Abstract

    Rugo, H. S.; Bardia, A.; Marme, F.; Cortes, J.; Schmid, P.; Loirat, D.; Tredan, O.; Ciruelos, E.; Dalenc, F.; Pardo, P. G.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Assessing 2024 oncology advances and looking ahead
    Editorial

    Iyengar, N. M.
    Oncology (Norwalk) (2024)

    Fulltext@MSK | Save
  • Imlunestrant, an oral selective estrogen receptor degrader, as monotherapy and in combination with targeted therapy in estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: Phase Ia/Ib EMBER study
    Journal Article

    Jhaveri, K. L.; Lim, E.; Jeselsohn, R.; Ma, C. X.; Hamilton, E. P.; Osborne, C.; Bhave, M.; Kaufman, P. A.; Beck, J. T.; Sanchez, L. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Patient characteristics associated with intended nonguideline chemotherapy in women with stage I to IIIA breast cancer
    Journal Article

    Bhimani, J.; O'Connell, K.; Persaud, S.; Blinder, V.; Burganowski-Doud, R. P.; Ergas, I. J.; Gallagher, G. B.; Griggs, J. J.; Heon, N.; Kolevska, T.; more...
    Cancer Epidemiology Biomarkers and Prevention (2024)

    Fulltext@MSK | Save
  • Advancing global health equity in oncology clinical trial access
    Editorial

    Bloomberg New Economy International Cancer Coalition; McKinsey Cancer Center; Cure4Cancer
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Automated real-world data integration improves cancer outcome prediction
    Journal Article

    Jee, J.; Fong, C.; Pichotta, K.; Tran, T. N.; Luthra, A.; Waters, M.; Fu, C.; Altoe, M.; Liu, S. Y.; Maron, S. B.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • Phase I/Ib trial of inavolisib plus palbociclib and endocrine therapy for PIK3CA-mutated, hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced or metastatic breast cancer
    Journal Article

    Jhaveri, K. L.; Accordino, M. K.; Bedard, P. L.; Cervantes, A.; Gambardella, V.; Hamilton, E.; Italiano, A.; Kalinsky, K.; Krop, I. E.; Oliveira, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A pooled analysis of trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer with brain metastases
    Journal Article

    André, F.; Cortés, J.; Curigliano, G.; Modi, S.; Li, W.; Park, Y. H.; Chung, W. P.; Kim, S. B.; Yamashita, T.; Pedrini, J. L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Unique structural configuration of EV-DNA primes Kupffer cell-mediated antitumor immunity to prevent metastatic progression
    Journal Article

    Wortzel, I.; Seo, Y.; Akano, I.; Shaashua, L.; Tobias, G. C.; Hebert, J.; Kim, K. A.; Kim, D.; Dror, S.; Liu, Y.; more...
    Nature Cancer (2024)

    Fulltext@MSK | Save